Related Experiment Video
Updated: Jan 17, 2026

13:19
Deep Neural Networks for Image-Based Dietary Assessment
Published on: March 13, 2021
9.9K
Systematic Review on Deep Learning Algorithms for Blood Glucose Forecasting in Type 1 Diabetes
IEEE Journal of Biomedical and Health Informatics
|January 14, 2026
Summary
Deep learning (DL) models show promise for predicting blood glucose (BG) levels in Type 1 Diabetes (T1D) using continuous glucose monitoring (CGM) data. Future research should integrate explainable AI (XAI) for improved clinical reliability and safety.
Area of Science:
- Endocrinology and Metabolism
- Artificial Intelligence in Medicine
- Biomedical Data Science
Background:
- Type 1 Diabetes (T1D) management relies on continuous glucose monitoring (CGM) for real-time blood glucose (BG) data.
- Forecasting algorithms, particularly deep learning (DL), leverage CGM data to predict future BG levels, aiding therapeutic interventions.
- A comprehensive review of DL applications for BG prediction is needed to guide clinical adoption.
Purpose of the Study:
- To systematically review the current state of deep learning applications for blood glucose prediction in Type 1 Diabetes.
- To evaluate DL models based on dataset characteristics, inputs, training, architecture, and performance metrics.
- To identify challenges and future research directions for DL-based BG forecasting.
Main Methods:
- Systematic literature review following PRISMA guidelines.
- Searches conducted across PubMed, Scopus, and Web of Science databases.
- Analysis of 26 selected studies focusing on DL models for BG prediction in T1D.
Main Results:
- Deep learning models demonstrate significant potential for accurate BG forecasting using CGM data.
- Evaluated studies varied in dataset characteristics, model inputs, architectures, and prediction horizons.
- Key challenges include ensuring physiological fidelity and interpretability of DL models for clinical use.
Conclusions:
- Deep learning models offer a promising approach for real-time BG prediction in T1D management.
- Explainable AI (XAI) integration is crucial for enhancing model reliability, safety, and clinical adoption.
- Future research should focus on developing interpretable and physiologically sound DL models for T1D care.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Hypoglycemia and Glucagon
835
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
835
Feedback Loops
64.1K
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
64.1K
Hormones Regulating Blood Glucose
6.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K

